Press release
United States Low-Grade Glioma Market to Reach USD 1.87 Billion by 2033, Led by Novartis, Roche, Merck and Bristol-Myers | DataM Intelligence
low-grade glioma market
United States: Recent Industry Developments
✅ In October 2025, Novartis received FDA approval for a novel targeted therapy specifically for IDH-mutant low-grade gliomas.
✅ In October 2025, The National Cancer Institute launched a multi-center clinical trial for combination therapies in pediatric low-grade glioma.
✅ In October 2025, A major US cancer center implemented AI-based imaging analysis for early detection and monitoring of low-grade glioma progression.
Japan: Recent Industry Developments
✅ In October 2025, Takeda Pharmaceutical introduced a new molecular diagnostic test for precise classification of low-grade glioma subtypes.
✅ In October 2025, Japan's Pharmaceuticals and Medical Devices Agency approved a minimally invasive surgical device for glioma resection.
✅ In October 2025, A Japanese research consortium identified new biomarkers for predicting treatment response in low-grade glioma patients.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/low-grade-glioma-market?jd
Market Trends & Drivers
The Low-Grade Glioma Market is experiencing steady growth driven by advancements in molecular diagnostics, targeted therapies, and improved surgical techniques. Key trends include the development of IDH inhibitor therapies, integration of genomic profiling in treatment decisions, and adoption of minimally invasive surgical approaches. The growing understanding of glioma biology, increasing precision medicine applications, and rising healthcare investments in neuro-oncology are significantly accelerating market expansion and treatment innovation.
Competitive Landscape
The market features specialized competition among pharmaceutical companies and biotechnology firms focusing on neuro-oncology.
Novartis AG leads with targeted therapies and ongoing research in molecularly-defined glioma treatments.
Roche Holding AG advances its oncology portfolio with specialized approaches for low-grade glioma management.
Merck & Co., Inc. develops immunotherapy and targeted treatment options for glioma patients.
Bristol-Myers Squibb Company investigates novel mechanisms for low-grade glioma therapy through clinical trials.
Pfizer Inc. maintains research programs in neuro-oncology with focus on targeted therapeutic approaches.
Eli Lilly and Company specializes in kinase inhibitors and novel mechanisms for brain tumor treatment.
Bayer AG explores innovative treatment approaches for central nervous system tumors.
AstraZeneca PLC invests in research for molecularly-targeted therapies in neuro-oncology.
Johnson & Johnson develops comprehensive solutions including pharmaceuticals and surgical technologies.
Takeda Pharmaceutical Company Limited focuses on specialized treatments for rare oncology indications.
Segmentation
By Drug Type (Trametinib, Dabrafenib, Ivosidenib, Mirdametinib)
By Treatment Type (Surgery, Chemotherapy, Radiation Therapy)
By Route of Administration (Oral, Topical)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/low-grade-glioma-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
DataM Intelligence is a full-service market research and consulting firm, guiding organizations from initial insight to strategic implementation. We transform proprietary data, emerging trends, and market developments into agile, actionable solutions.
Our robust methodology powers a vast research database featuring 6,300+ syndicated and custom reports across 40+ industries. We have delivered strategic solutions to 200+ companies in 50+ countries, addressing the core research challenges that drive growth for our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Low-Grade Glioma Market to Reach USD 1.87 Billion by 2033, Led by Novartis, Roche, Merck and Bristol-Myers | DataM Intelligence here
News-ID: 4232511 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of…
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad
United States: Recent Industry…
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market.
Download your exclusive sample report today: (corporate email gets priority access):…
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market.
Download your exclusive sample report today: (corporate…
More Releases for October
Dogecoin Price Prediction In October
Dogecoin Price Prediction is on the radar this October as investors monitor whether the meme cryptocurrency can sustain its bullish formation in light of broader market volatilities. With rising interest in utility-driven assets and renewed optimism around strong community tokens, Dogecoin remains one of the top cryptocurrencies to consider right now.
While Dogecoin was conceived as a meme coin, it has grown into a legitimate market force with strong liquidity, a…
October Headlining Shows In Vegas
Upcoming Headlining Shows In Las Vegas
OCTOBER 2024
now - 10/27
Sistahs! The Hocus Pocus Parody
now - 10/19
Earth, Wind and Fire
now - 10/19
Eagles
now - 10/26
Carrie Underwood: REFLECTION
now - 10/19
Barry Manilow: The Hits Come Home
10/18
When We Were Young Sideshow:
The Used and Taking Back Sunday
10/18
Tommy James & The Shondells
10/18 - 10/19
Toni Braxton and Cedric The Entertainer
10/18 - 10/19
Brad Paisley
10/18 - 10/26
Lenny Kravitz
10/19
Porter Robinson
10/19
Parker McCollum
10/19 - 10/20
When We Were Young Festival
10/19 - 10/20
Nick Swardson
10/20
Jeff Dunham: Still…
The Second Line Film Festival enters its 2nd year October 14 – October 18
New Orleans, La ( October 15, 2020) The Second Line Film Festival is an exciting virtual event produced by Gloried Media, LLC, the producers of the South Carolina Cultural Film Festival and the Charlotte Black Film Festival. After participating in the New Orleans cultural scene and serving as a producer for the Real Caregivers of New Orleans Mr. Nichols president of Glorified Media, LLC. fell in love with the people…
ProviNET Solutions exhibits at Leading Age Dallas on October 27 – October 30
A Leading Provider of Healthcare IT Solutions Participates in Leading Age Dallas Annual Meeting and Expo
Tinley Park, IL (September, 2013) ProviNET Solutions is a full-service IT company that offers a comprehensive spectrum of technology products and services for senior living facilities throughout the United States. Born from a long-term care provider, ProviNET is familiar with the strict demands and urgent needs of the industry. ProviNET focuses on ways to…
October Trade Show Triathlon
A high-intensity program of three events for rational motion and TM4 in Germany.
Cologne, October 9, 2012
October is marathon month for rational motion and partner enterprise TM4. With three events following close on one another, the two companies are on tour for electric powertrains and vehicle integration throughout the month. The grand finale will be a joint booth at the eCarTec in Munich. Though the three events differ greatly, they all…
Florida: October is "Guardianship Month"
Florida Governor Charlie Crist has declared October as “Guardianship Month.”
NASGA would point Governor Crist’s attention to the fact that the original intent of guardianship/conservatorship law - “guard,” “protect” and “conserve” - is no longer being complied with in a frightening and growing number of cases involving court-appointed fiduciaries. Wards' estates, instead of being conserved, are being plundered in the guise of fiduciary fee billings for "services," either not…
